• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    61 Biggest Movers From Yesterday

    4/28/22 4:17:36 AM ET
    $AFIB
    $AGRX
    $ALKS
    $APCX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AFIB alert in real time by email

    Gainers

    • Vivakor, Inc. (NASDAQ:VIVK) shares jumped 113.5% to close at $3.65 on Wednesday after the company announced it has signed a 10-year contract with Hot Oil Transport with a potential value of up to $250 million.
    • Acutus Medical, Inc. (NASDAQ:AFIB) gained 36% to settle at $1.09 after the company announced agreements to fund strategic growth priorities.
    • Locafy Limited (NASDAQ:LCFY) jumped 34.2% to close at $1.57.
    • Cosmos Holdings Inc. (NASDAQ:COSM) shares gained 34% to close at $1.42 after jumping over 16% on Tuesday. Cosmos Holdings recently posted FY21 adjusted net income of $384K.
    • Tempest Therapeutics, Inc. (NASDAQ:TPST) surged 30.1% to close at $3.07. Tempest reported a $15 million private placement financing.
    • Studio City International Holdings Limited (NYSE:MSC) gained 29.7% to close at $5.45.
    • Canterbury Park Holding Corporation (NASDAQ:CPHC) surged 22.2% to settle at $32.92. Canterbury Park, last month, reported fourth-quarter FY21 sales growth of 128% year-on-year, to $13.95 million.
    • Bon Natural Life Limited (NASDAQ:BON) gained 18.5% to close at $4.54. Bon Natural Life recently announced plans to launch new multi-functional health supplements.
    • Elevation Oncology, Inc. (NASDAQ:ELEV) jumped 17.8% to close at $2.84.
    • PAVmed Inc. (NASDAQ:PAVM) gained 16.5% to settle at $1.27.
    • AppTech Payments Corp. (NASDAQ:APCX) gained 15.9% to settle at $1.68.
    • Chindata Group Holdings Limited (NASDAQ:CD) surged 15.3% to close at $5.79.
    • Medigus Ltd. (NASDAQ:MDGS) gained 15.2% to close at $1.0783. Medigus' ParaZero recently signed an agreement to develop custom safety solution for a leading global automotive manufacturer's drone program.
    • TradeUP Global Corporation (NASDAQ:TUGC) climbed 15.1% to settle at $10.59.
    • Atossa Therapeutics, Inc. (NASDAQ:ATOS) gained 15% to close at $1.11. Atossa Therapeutics recently announced completion of Part B of clinical study of AT-H201.
    • Direct Digital Holdings, Inc. (NASDAQ:DRCT) gained 15% to close at $2.53.
    • Alliance Resource Partners, L.P. (NASDAQ:ARLP) jumped 14.9% to close at $18.16. Alliance Resource Partners sees net income of $0.27-$0.28 per basic and diluted limited partner unit for 2022 quarter.
    • Nutex Health, Inc. (NASDAQ:NUTX) rose 13.5% to close at $8.72 after jumping 74% on Tuesday.
    • Nordic American Tankers Limited (NYSE:NAT) climbed 12.9% to settle at $2.88.
    • Ardmore Shipping Corporation (NYSE:ASC) gained 12.8% to close at $6.33.
    • Alkermes plc (NASDAQ:ALKS) rose 11.9% to close at $30.38 following better-than-expected Q1 results.
    • Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) gained 11.8% to close at $24.41. Pfizer agreed to invest $25 million in Zentalis Pharmaceuticals via the purchase of 953,834 shares at $26.21 per share.
    • Vertiv Holdings Co (NYSE:VRT) rose 11.5% to close at $12.87 following upbeat Q1 results.
    • Mattel, Inc. (NASDAQ:MAT) gained 10.8% to close at $24.49 following a WSJ report suggesting the company is in talks with private-equity firms about a potential sale.
    • Repligen Corporation (NASDAQ:RGEN) shares jumped 10.5% to close at $157.51 after reporting upbeat Q1 results.
    • JinkoSolar Holding Co., Ltd. (NYSE:JKS) gained 9.7% to close at $55.09.
    • Digital World Acquisition Corp. (NASDAQ:DWAC) rose 9.2% to close at $44.55.
    • Bilibili Inc. (NASDAQ:BILI) gained 8.1% to close at $22.23.
    • Enphase Energy, Inc. (NASDAQ:ENPH) gained 7.7% to close at $165.71 after the company reported better-than-expected Q1 adjusted EPS and sales results and issued Q2 sales guidance above analyst estimates.
    • Visa Inc. (NYSE:V) rose 6.5% to close at $214.11 following upbeat quarterly earnings.
    • Microsoft Corporation (NASDAQ:MSFT) rose 4.8% to close at $283.22 as the company reported better-than-expected results for its third quarter.


    Losers

    • JE Cleantech Holdings Limited (NASDAQ:JCSE) dipped 68.4% to close at $5.12 on Wednesday.
    • Molecular Partners AG (NASDAQ:MOLN) shares fell 36.9% to close at $8.70. The company’s collaborating partner Amgen for MP0310 (AMG 506) will return the global rights of MP0310 to Molecular Partners following a strategic pipeline review.
    • Agile Therapeutics, Inc. (NASDAQ:AGRX) dipped 29.9% to settle at $3.14 following effectiveness of 1:40 reverse stock split.
    • Q&K International Group Limited (NASDAQ:QK) shares fell 25.4% to close at $0.88 after jumping around 19% on Tuesday.
    • Silence Therapeutics plc (NASDAQ:SLN) fell 23.6% to settle at $11.07.
    • NCR Corporation (NYSE:NCR) fell 23.2% to close at $28.67 after the company reported worse-than-expected Q1 EPS and sales results. The company also cut its FY22 EPS and sales guidance.
    • Evoke Pharma, Inc. (NASDAQ:EVOK) fell 23.2% to close at $0.66. Evoke Pharma shares jumped over 118% on Tuesday as the FDA granted new drug product exclusivity to Evoke Pharma's Gimoti (metoclopramide) nasal spray to relieve symptoms associated with acute and recurrent diabetic gastroparesis in adults.
    • Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) dipped 22.8% to close at $0.21. Salarius Pharmaceuticals recently announced a $2.3 million registered direct offering.
    • Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) fell 19.7% to close at $10.44. Rani Therapeutics, last month, posted a Q4 loss of $0.27 per share.
    • Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) fell 18.4% to close at $5.80. Diffusion Pharmaceuticals recently company announced a 1-for-50 reverse stock split.
    • Forge Global Holdings, Inc. (NYSE:FRGE) fell 18% to close at $15.13.
    • Solid Biosciences Inc. (NASDAQ:SLDB) dipped 17% to close at $0.6434. Solid Biosciences is shaving down its pipeline, updating its operations strategy to prioritize the advancement of AAV-mediated gene transfer therapies, SGT-001 and SGT-003.
    • iSpecimen Inc. (NASDAQ:ISPC) dropped 16.9% to close at $3.19.
    • Extreme Networks, Inc. (NASDAQ:EXTR) fell 16.8% to close at $9.40 following Q3 results.
    • ToughBuilt Industries, Inc. (NASDAQ:TBLT) dipped 16.6% to settle at $12.10. ToughBuilt Industries reported a 41% online sales growth through Amazon in Q1.
    • Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) dropped 16.5% to close at $0.9101. Citius Pharmaceuticals enrolled first patient in Phase 2b study of Halo-lido for the prescription treatment of haemorrhoids.
    • Sono Group N.V. (NASDAQ:SEV) fell 16.4% to close at $4.93 after the company reported a 10 million share follow-on offering.
    • IDEX Biometrics ASA (NASDAQ:IDBA) dipped 15.7% to close at $10.98.
    • Avenue Therapeutics, Inc. (NASDAQ:ATXI) fell 14.9% to settle at $0.3697.
    • ION Geophysical Corporation (NYSE:IO) declined 14.7% to close at $0.4945. Alliance Global Partners downgraded the stock from Buy to Sell.
    • Tian Ruixiang Holdings Ltd (NASDAQ:TIRX) dropped 14.6% to close at $0.7670.
    • F5, Inc. (NASDAQ:FFIV) fell 12.8% to close at $169.01 after the company reported Q2 earnings results and issued Q3 sales guidance below analyst estimates.
    • Spotify Technology S.A. (NYSE:SPOT) dipped 12.4% to settle at $96.67 after the company reported Q1 financial results.
    • Bright Minds Biosciences Inc. (NASDAQ:DRUG) fell 9.4% to close at $1.06.
    • Diebold Nixdorf, Incorporated (NYSE:DBD) dropped 8.5% to close at $4.32.
    • Hawaiian Holdings, Inc. (NASDAQ:HA) dropped 8.2% to close at $17.04 following Q1 results.
    • Trinity Industries, Inc. (NYSE:TRN) fell 8.1% to close at $28.15 following downbeat quarterly results.
    • Deutsche Bank Aktiengesellschaft (NYSE:DB) shares fell 6.9% to close at $10.13 following Q1 earnings.
    • Capital One Financial Corporation (NYSE:COF) fell 6% to settle at $124.35 after the company reported Q1 earnings results.
    • Alphabet Inc. (NASDAQ:GOOGL) fell 3.7% to close at $2,285.89 following downbeat quarterly earnings.
    Get the next $AFIB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AFIB
    $AGRX
    $ALKS
    $APCX

    CompanyDatePrice TargetRatingAnalyst
    Microsoft Corporation
    $MSFT
    2/5/2026$392.00Buy → Hold
    Stifel
    Enphase Energy Inc.
    $ENPH
    2/4/2026$52.00Hold → Buy
    HSBC Securities
    Enphase Energy Inc.
    $ENPH
    2/4/2026$41.00Underperform → Market Perform
    BMO Capital Markets
    Enphase Energy Inc.
    $ENPH
    2/4/2026$54.00Sector Perform → Outperform
    RBC Capital Mkts
    Enphase Energy Inc.
    $ENPH
    2/4/2026$35.00 → $40.00Hold
    TD Cowen
    Visa Inc.
    $V
    2/3/2026$370.00Neutral → Outperform
    Daiwa Securities
    Microsoft Corporation
    $MSFT
    2/3/2026$600.00Overweight
    Piper Sandler
    Spotify Technology S.A.
    $SPOT
    1/30/2026$650.00Neutral → Buy
    Citigroup
    More analyst ratings

    $AFIB
    $AGRX
    $ALKS
    $APCX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    iSpecimen Announces Milestone 2: System Integration and Marketplace Activation Complete

    Live Production Marketplace Now AvailableWoburn, Massachusetts--(Newsfile Corp. - February 6, 2026) - iSpecimen Inc. (NASDAQ:ISPC) today announced the successful completion of Milestone 2, System Integration and Marketplace Activation, marking a pivotal step in the SalesStack digital transformation journey. The milestone delivers a fully integrated, live marketplace that connects customer requests with supplier inventories, enabling streamlined operations, reduced costs, and a foundation for future growth.Chief Executive Officer Ms. Katie Field commented, "This Milestone 2 achievement demonstrates end-to-end system integration, legacy data migration, and activation of a production-ready Sale

    2/6/26 9:30:00 AM ET
    $ISPC
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    TIAN RUIXIANG Ignites a Digital Financial Revolution: 15,000 BTC Powerhouse Alliance Surges Toward Historic Government-backed Stablecoin Issuance Dominance in Key Southeast Asia Countries

    Beijing, Feb. 06, 2026 (GLOBE NEWSWIRE) -- In a seismic move set to redefine the global digital asset landscape and crown a new era of AI-driven crypto supremacy, TIAN RUIXIANG Holdings Ltd. (NASDAQ:TIRX, the "Company")) — today dropped a bombshell update: its epoch-making partnership with a titanic global digital asset investor, forged with a 15,000 Bitcoin ("BTC") injection, has erupted into a game-changing stablecoin initiative, now hurtling through the decisive and mature stretch of negotiations with government leaders across Southeast Asia's most influential nations. This is not merely an expansion — it is a full-throttle charge to seize control of the world's fastest-growing digital

    2/6/26 9:15:00 AM ET
    $TIRX
    Specialty Insurers
    Finance

    iSpecimen Achieves Rapid Procurement Milestone for Influenza Research

    Lexington, Massachusetts--(Newsfile Corp. - February 6, 2026) - iSpecimen Inc. (NASDAQ:ISPC), a leading provider of human biospecimens for research, is proud to announce recent milestones that demonstrate the strength, responsiveness, and reliability of its site network.Over the past several months, iSpecimen has been actively supporting customer research by sourcing high-quality respiratory samples, with a particular focus on influenza. Most recently, iSpecimen successfully collected 500 influenza swab samples in just a few weeks to support a customer research project—demonstrating its ability to respond quickly to time-sensitive research needs. The rapid turnaround and quality of the speci

    2/6/26 8:20:00 AM ET
    $ISPC
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    $AFIB
    $AGRX
    $ALKS
    $APCX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Microsoft downgraded by Stifel with a new price target

    Stifel downgraded Microsoft from Buy to Hold and set a new price target of $392.00

    2/5/26 6:54:30 AM ET
    $MSFT
    Computer Software: Prepackaged Software
    Technology

    Enphase Energy upgraded by HSBC Securities with a new price target

    HSBC Securities upgraded Enphase Energy from Hold to Buy and set a new price target of $52.00

    2/4/26 10:18:44 AM ET
    $ENPH
    Semiconductors
    Technology

    Enphase Energy upgraded by BMO Capital Markets with a new price target

    BMO Capital Markets upgraded Enphase Energy from Underperform to Market Perform and set a new price target of $41.00

    2/4/26 8:24:40 AM ET
    $ENPH
    Semiconductors
    Technology

    $AFIB
    $AGRX
    $ALKS
    $APCX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for GIMOTI

    Submission status for EVOKE PHARMA INC's drug GIMOTI (SUPPL-1) with active ingredient METOCLOPRAMIDE HYDROCHLORIDE has changed to 'Approval' on 01/14/2021. Application Category: NDA, Application Number: 209388, Application Classification: Labeling

    1/15/21 5:10:35 AM ET
    $EVOK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AFIB
    $AGRX
    $ALKS
    $APCX
    SEC Filings

    View All

    Capital One Financial Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - CAPITAL ONE FINANCIAL CORP (0000927628) (Filer)

    2/6/26 4:34:01 PM ET
    $COF
    Major Banks
    Finance

    Tempest Therapeutics Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Changes in Control of Registrant

    8-K - Tempest Therapeutics, Inc. (0001544227) (Filer)

    2/6/26 4:12:27 PM ET
    $TPST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    iSpecimen Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - iSpecimen Inc. (0001558569) (Filer)

    2/6/26 4:05:23 PM ET
    $ISPC
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    $AFIB
    $AGRX
    $ALKS
    $APCX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President & CEO Kothandaraman Badrinarayanan bought $259,884 worth of shares (5,000 units at $51.98) (SEC Form 4)

    4 - Enphase Energy, Inc. (0001463101) (Issuer)

    2/5/26 4:41:25 PM ET
    $ENPH
    Semiconductors
    Technology

    Chief Executive Officer Siokas Grigorios bought $45,000 worth of shares (90,325 units at $0.50), increasing direct ownership by 1% to 8,182,120 units (SEC Form 4)

    4 - Cosmos Health Inc. (0001474167) (Issuer)

    1/26/26 11:48:12 AM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    Chief Executive Officer Siokas Grigorios bought $175,000 worth of shares (353,321 units at $0.50), increasing direct ownership by 5% to 8,091,795 units (SEC Form 4)

    4 - Cosmos Health Inc. (0001474167) (Issuer)

    1/21/26 10:11:57 AM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    $AFIB
    $AGRX
    $ALKS
    $APCX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Pichai Sundar sold $10,893,259 worth of Class C Capital Stock (32,500 units at $335.18), was granted 1,348,607 units of Class C Capital Stock and covered exercise/tax liability with 676,955 units of Class C Capital Stock, increasing direct ownership by 29% to 2,851,024 units (SEC Form 4)

    4 - Alphabet Inc. (0001652044) (Issuer)

    2/6/26 7:36:40 PM ET
    $GOOGL
    Computer Software: Programming Data Processing
    Technology

    Director and CEO, Alkermes plc Pops Richard F was granted 149,580 units of Ordinary Shares and covered exercise/tax liability with 62,230 units of Ordinary Shares, increasing direct ownership by 7% to 1,377,740 units (SEC Form 4)

    4 - Alkermes plc. (0001520262) (Issuer)

    2/6/26 7:14:03 PM ET
    $ALKS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SVP, Chief Commercial Officer Nichols Christian Todd was granted 21,127 units of Ordinary Shares and covered exercise/tax liability with 6,389 units of Ordinary Shares, increasing direct ownership by 17% to 100,946 units (SEC Form 4)

    4 - Alkermes plc. (0001520262) (Issuer)

    2/6/26 7:13:20 PM ET
    $ALKS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AFIB
    $AGRX
    $ALKS
    $APCX
    Leadership Updates

    Live Leadership Updates

    View All

    Aptera Motors Appoints Automotive Industry Veteran Tony Kirton as Chairman of the Board of Directors

    CARLSBAD, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Aptera Motors Corp. (NASDAQ:SEV), a solar mobility company advancing ultra-efficient transportation, today announced that Tony Kirton has been appointed Chairman of the Board of Directors. Kirton brings more than four decades of global automotive leadership experience, having held senior executive and board roles across leading automotive brands including Volkswagen, Audi, and BMW. His appointment follows his service as an independent board director and supports Aptera's focus on disciplined governance and long-term value creation as the company prepares for production. "Over my career, I've seen many technologies promise transformation

    1/8/26 4:49:26 PM ET
    $SEV
    Auto Manufacturing
    Industrials

    Hawaiian Airlines, a part of Alaska Airlines, announces Kahu'ewai Hawai'i Investment Plan of more than $600M over five years to modernize infrastructure and guest experience, and deepen its commitment to the community and sustainability

    Major airport renovations include improved lobbies, gates, and amenities at Honolulu, Līhu'e, Kahului, Kona, and Hilo, plus a new premium lounge in Honolulu.The airline will update its app and website, offering better travel planning and self-service features, and invest in new technology for employees.The carrier is investing in a refreshed onboard experience with upgraded widebody Airbus A330 interiors, while offering enhanced rewards and exclusive benefits to loyal Hawai'i residents.HONOLULU, Jan. 5, 2026 /PRNewswire/ -- Hawaiian Airlines, a part of Alaska Airlines, today unveiled an investment plan of more than $600 million over five years to comprehensively enhance the experience for gu

    1/5/26 2:00:00 PM ET
    $ALK
    $HA
    Air Freight/Delivery Services
    Consumer Discretionary

    JinkoSolar Announces Results of 2025 Annual General Meeting

    SHANGRAO, China, Dec. 29, 2025 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") (NYSE:JKS), one of the largest and most innovative solar module manufacturers in the world, today announced that all shareholders resolutions proposed at the Company's 2025 annual general meeting held today were duly passed. Specifically, the Company's shareholders passed the following ordinary resolutions approving: The re-election of Mr. Haiyun Cao as a director of the Company;The re-election of Mr. Wing Keong Siew as an independent director of the Company;The ratification of the appointment of PricewaterhouseCoopers Zhong Tian LLP as auditors of the Company for the fiscal year of 2

    12/29/25 12:13:00 AM ET
    $JKS
    Semiconductors
    Technology

    $AFIB
    $AGRX
    $ALKS
    $APCX
    Financials

    Live finance-specific insights

    View All

    Enphase Energy Reports Financial Results for the Fourth Quarter of 2025

    FREMONT, Calif., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Enphase Energy, Inc. (NASDAQ:ENPH), a global energy technology company, announced today financial results for the fourth quarter of 2025, which included the summary below from its President and CEO, Badri Kothandaraman. We reported quarterly revenue of $343.3 million in the fourth quarter of 2025, along with 46.1% for non-GAAP gross margin. We shipped approximately 1.55 million microinverters, or 682.6 megawatts DC, and 150.1 megawatt hours (MWh) of IQ® Batteries. Highlights for the fourth quarter of 2025 are listed below: Revenue of $343.3 millionGAAP gross margin of 44.3% and non-GAAP gross margin of 46.1%, including 5.1% of tariff im

    2/3/26 4:05:00 PM ET
    $ENPH
    Semiconductors
    Technology

    Capital One Announces Quarterly Dividend

    Company also declares preferred stock dividend Capital One Financial Corporation (NYSE:COF) today announced a quarterly dividend of $0.80 per common share payable March 2, 2026, to stockholders of record at the close of business on February 19, 2026. The company has announced dividends on its common stock every quarter since it became an independent company on February 28, 1995. Dividends declared by the company are eligible for direct reinvestment in the company's common stock under its Dividend Reinvestment and Stock Purchase Plan. For additional Plan information, stockholders should contact Computershare Trust Company, N.A., at 1-888-985-2057 (inside the U.S. and Canada) or 1-781-575-2

    2/3/26 8:05:00 AM ET
    $COF
    Major Banks
    Finance

    Vivakor Signs Letter of Intent to Sell its Midstream Business in Oklahoma STACK Play for $36 Million to Olenox Industries

    Dallas, TX, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Vivakor, Inc. (OTC:VIVK) ("Vivakor" or the "Company"), an integrated provider of energy transportation, storage, reuse, and remediation service, today announced that it has executed a non-binding Letter of Intent to sell its midstream business and transportation assets of CPE Gathering MidCon, LLC ("CPE Gathering") to Olenox Industries, Inc. (NASDAQ:OLOX) for approximately $36 million. Vivakor is the owner and operator of the Omega pipeline system, an integrated crude-oil gathering, transportation, terminaling and pipeline connection platform serving the Oklahoma STACK play. The transaction, valued at approximately $36 million, will be paid i

    2/2/26 8:30:00 AM ET
    $OLOX
    $VIVK
    RETAIL: Building Materials
    Consumer Discretionary
    Environmental Services
    Utilities

    $AFIB
    $AGRX
    $ALKS
    $APCX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Acutus Medical Inc.

    SC 13D/A - Acutus Medical, Inc. (0001522860) (Subject)

    12/16/24 9:52:56 PM ET
    $AFIB
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Amendment: SEC Form SC 13D/A filed by Citius Pharmaceuticals Inc.

    SC 13D/A - Citius Pharmaceuticals, Inc. (0001506251) (Subject)

    11/27/24 4:05:31 PM ET
    $CTXR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Direct Digital Holdings Inc.

    SC 13D/A - Direct Digital Holdings, Inc. (0001880613) (Subject)

    11/22/24 4:11:23 PM ET
    $DRCT
    Advertising
    Consumer Discretionary